Sensei Biotherapeutics, Inc. (SNSE)

Sensei Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	13.01	17.8	7.16	16.6	0.7
Short-Term Investments	52.75	89.32	140.46	0	0
Cash & Cash Equivalents	65.76	107.12	147.62	16.6	0.7
Cash Growth	-38.61%	-27.44%	789.50%	2277.65%	-36.55%
Other Current Assets	1.49	1.47	0.92	3.48	-0.2
Total Current Assets	67.25	108.59	148.54	20.08	0.5
Property, Plant & Equipment	7.04	9.72	4.64	1.27	0.27
Other Long-Term Assets	0.09	0.06	0.04	0.09	0.45
Total Long-Term Assets	7.12	9.79	4.68	1.35	0.72
Total Assets	74.37	118.38	153.23	21.43	1.22
Accounts Payable	1.69	4.47	2.46	3.88	3.55
Current Debt	2.44	2.13	0.68	0.03	16.06
Other Current Liabilities	1.51	2.46	1.75	0.92	2.11
Total Current Liabilities	5.64	9.07	4.89	4.83	21.71
Long-Term Debt	3.77	5.9	1.67	0.65	0
Other Long-Term Liabilities	0.07	0	0.15	0.05	0.62
Total Long-Term Liabilities	3.84	5.9	1.82	0.71	0.62
Total Liabilities	9.48	14.97	6.71	5.54	22.33
Total Debt	6.21	8.03	2.35	0.69	16.06
Debt Growth	-22.72%	241.25%	243.65%	-95.73%	238.28%
Retained Earnings	-231.9	-197.79	-149.21	-112.41	-92.31
Comprehensive Income	-0.21	-1	-0.33	0	0
Shareholders' Equity	64.9	103.41	146.51	-56.44	-68.66
Net Cash / Debt	59.55	99.08	145.27	15.91	-15.36
Net Cash / Debt Growth	-39.90%	-31.79%	813.00%	-	-
Net Cash Per Share	2.13	3.23	5.24	9.87	-41.80
Working Capital	61.61	99.52	143.65	15.25	-21.21
Book Value Per Share	2.32	3.37	5.29	-35.01	-186.91

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).